UBS Asset Management United Kingdom Please read the terms and conditions set out below and confirm your acceptance at the bottom of the page.

This website is a marketing communication. Any market or investment views expressed are not intended to be investment research. The website has not been prepared in line with the Financial Conduct Authority requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The information contained in this website should not be considered a recommendation to purchase or sell any particular security and the opinions expressed are those of UBS Asset Management and are subject to change without notice. Furthermore, there can be no assurance that any trends described in this website will continue or that forecasts will occur because economic and market conditions change frequently.

Persons who access the material made available by UBS Asset Management (UK) Ltd at this website ("UBS website”) agree to the following:

About this site
The material on the UBS Asset Management UK Intermediary web site is aimed at UK Professional Clients including Financial Advisers. It is not aimed at, and must not be relied upon by, Retail Clients. This website is not directed at persons in any other jurisdiction, including the United States. This information is not an invitation to subscribe for units or shares in the funds described herein and is by way of information only.

UBS does not give investment advice or recommendations in respect of its product range.

The UK Intermediary web site includes both regulated and unregulated products. You should be aware that unregulated products do not carry the same degree of protection as regulated products. Unregulated schemes may only be marketed to clients in accordance with Chapter 4 of the FCA’s New Conduct of Business Sourcebook (COBS) and the Financial Services and Markets Act 2000 (Promotion of Collective Investment Schemes) Exemptions Order 2001, as amended.

Use of the UBS website
The entire content of this UBS website is subject to copyright with all rights reserved. You may download or print out a hard copy of individual pages and/or sections of the UBS website, provided that you do not remove any copyright or other proprietary notices. Any downloading or otherwise copying from the UBS website will not transfer title to any software or material to you. You may not reproduce (in whole or in part), transmit (by electronic means or otherwise), modify, link into or use for any public or commercial purpose, the UBS website without the prior written permission of UBS.

No reliance or advice
While UBS uses reasonable efforts to obtain information from sources which it believes to be reliable, UBS makes no representation that the information or opinions contained on the UBS website is accurate, reliable or complete. The information and opinions contained in the UBS website are provided by UBS for personal use and informational purposes only and are subject to change without notice. Nothing contained on the UBS website constitutes investment, legal, tax or other advice, nor is to be relied on in making an investment or other decision. You should obtain relevant and specific professional advice before making any investment decision.

Investment performance
The past is not a guide to the future performance of an investment. The value of investments may fall as well as rise and investors may not get back the amount invested. Changes in rates of foreign exchange may cause the value of investment to go up or down.

The levels of and reliefs from taxation may change. Tax reliefs referred to are those currently available and their value depends on the circumstances of the individual investor. Although an investment held within an ISA may be free of further tax to the investor, the fund itself may have incurred other forms of taxation.

Risk warnings:

  • The annual management fees of the funds featured on this website may be charged wholly or partly to the capital of the fund. Where this is the case, whilst it will increase the fund’s yield, it will cause erosion of the capital value and affect the performance of the fund.
  • The yield on income funds may vary and you should contact UBS or your financial adviser to obtain up to date figures.
  • Some UBS funds may invest in emerging markets, this involves a high degree of risk and should be seen as long term in nature.
  • Smaller companies funds may invest in companies which may be less liquid than larger companies and subsequent price swings may be greater as a result.
  • Some funds may use derivatives as part of their investment process. Such instruments are inherently volatile and the fund could be potentially exposed to additional risks and costs.

No offer 
Nothing on the UBS website should be construed as a solicitation or offer, or recommendation, to acquire or dispose of any investment or to engage in any other transaction.

No warranty 
The information and opinions contained on the UBS website is provided without any warranty of any kind, either express or implied.

Limitations of liability 
In no event, including (without limitation) negligence, will UBS be liable for any loss or damage of any kind, including (without limitation) any direct, special indirect or consequential damages, even if expressly advised of the possibility of such damages, arising out of or in connection with the access of, use of, performance of, browsing in or linking to other sites from the UBS website.

Material interests
The UBS Group and/or its directors, officers and employees may have or have had interests or positions or traded or acted as market makers in relevant securities. Furthermore, such entities or persons may have or have had a relationship with or may provide or have provided corporate finance or other services to or serve or have served as directors of relevant companies.

Local legal restrictions
The UBS website is not directed to any person in any jurisdiction where (by reason of that person’s nationality residence or otherwise) the publication or availability of the UBS website is prohibited. Persons in respect of whom such prohibitions apply must not access the UBS website.

Telephone calls
Telephone calls to UBS Asset Management may be recorded for your protection.

Data protection 
Information provided by you will be held in confidence by UBS Asset Management Funds Ltd and its properly appointed agents and will not be passed on to other product or service companies. Your information may be used to send you information on other products and services offered by UBS Asset Management, a division and subsidiary of UBS AG. If you prefer not to receive such information please contact UBS Asset Management. The use of your personal information is governed by the Data Protection Act 1998.

All of the material on this UBS website is directed only at UK residents and is not to be regarded as an offer to buy or sell, or the solicitation of any offer to buy or sell securities in any other jurisdiction other than the United Kingdom.

Legal and regulatory information 
UBS Asset Management Funds Ltd is the ISA manager and markets unit trust and OEIC products on behalf of UBS Asset Management. The investment manager is UBS Asset Management (UK) Ltd. Both are registered in England, subsidiaries of UBS AG and are authorised and regulated by the Financial Conduct Authority. The registered office of UBS Asset Management is 5 Broadgate, London, EC2M 2QS.



1. Is the UBS US 130/30 Equity Fund a hedge fund?
No, it is an equity fund that seeks to generate higher returns than a standard ‘long only' fund, with market risk similar to that of it's benchmark, the Russell 1000 Index. Also, US Equity 130/30 returns are expected to be highly correlated to the Russell 1000 Index. Hedge funds pursue uncorrelated absolute returns. This strategy does not pursue absolute returns.

2. Who may this Fund be suitable for?
The Fund may be suitable for investors looking for the potential of higher returns from investments in the US equity market, who are willing to accept a higher level of active risk.

3. What is the advantage of incorporating a long/short strategy into a portfolio?
In long-only portfolios, we can take meaningful active positions in undervalued stocks. However, we are limited to either underweighting or avoiding stocks that are overvalued. By relaxing the long-only constraint and enabling short positions in overvalued securities, we have the flexibility to pursue an additional source of alpha in overvalued stocks by effectively increasing the magnitude of the portfolio underweights.

4. Aren't quantitative managers better suited to offer this type of product because they analyse the entire benchmark?
Not necessarily. While it is true that they consider all stocks in a universe, they often take a large number of very small positions, and usually have a tracking error no higher than 5.0%. We have 27 research analysts* and therefore have the resources to evaluate and rank more than 500 stocks in the Russell 1000 Index using our Global Equity Valuation System (GEVS). Because we have performed detailed fundamental analysis, we are comfortable taking larger positions and larger tracking error, enabling us to more fully utilise our investment insights. Our fundamental strategy should have less correlated returns than those of quantitative managers.

*Source: UBS Asset Management as at 31 March 2008

5. Do short positions help to lessen the portfolio's downside?
No, this strategy seeks higher expected returns at levels of risk similar to that of the Russell 1000 Index.

6. Isn't shorting expensive?
UBS Asset Management is able to obtain the most competitive securities lending rates with top prime brokers. Because we are shorting primarily large capitalisation, liquid names, they are easy to borrow at a low cost.

7. Will your investment timeframe change because you are now shorting securities?
We expect holding periods for each security to be similar to that of our UBS US Equity Fund. However, we expect portfolio turnover to be higher because of the increased number of holdings and the increased gross exposure.

8. Doesn't shorting securities increase the riskiness of a portfolio?
Yes, if the short securities should go against us, then the size of the short positions would become larger and thus become a bigger contributor to active risk—as opposed to long positions that decline in value. Because of this increased risk, our short positions are meaningfully smaller than our long positions. Short positions account for about 20% of the total securities in the portfolio. The fund manager implements a limit of 3% of the Fund's overall net assets in a short position.

9. Isn't shorting in some way sinister or unpatriotic?
No, we are in the business of valuing companies. An excellent company can be overvalued and be a good short; conversely, a poorly run company could be undervalued and be a good long position - we are indifferent to the opportunity set.

Philosophically, as money managers we are capital allocators, and our job is to allocate capital to companies that are positioned to produce strong cash flows for the benefit of investors. By shorting stocks with lower return prospects, and then investing the short proceeds in companies with superior returns, we are simply allocating capital more efficiently.

10. Does the UBS US 130/30 Equity Fund employ leverage?
The Fund may use leverage; however, its net market exposure is expected to be 100%. The Fund's gross market exposure will normally range from 120% to 180%, with its long exposure ranging from 110% to 140%, and its short exposure ranging from 10% to 40%.

11. Why do you believe the Fund's investment team will be successful at shorting stocks? Doesn't shorting require a different skill set?
UBS Asset Management has a 25-year track record in successfully investing in underpriced stocks and avoiding overpriced stocks. By leveraging our expertise in this area, the strategy has the flexibility to pursue more alpha by shorting a select number of overvalued securities that we believe will underperform the market. Importantly, the UBS US 130/30 Equity Fund is managed by the same team as the UBS US Equity Fund, which has added value to our clients' portfolios for 25 years. Combining our proprietary Global Equity Valuation System (GEVS) with our state-of-the-art risk management system, the team seeks to identify securities with the potential for establishing the most rewarding long and short positions.

12. What investment strategies will US Equity 130/30 use to pursue added returns?
The investment team will seek to provide alpha by employing three main strategies: taking long positions in undervalued securities and taking short positions in overvalued securities.

13. How many securities will typically be in the Fund's portfolio?
The portfolio will typically contain 80 to 120 securities. Long positions will be comprised of 50 to 70 securities, with individual weights of approximately 1% to 4%; short positions will be comprised of 30 to 50 securities, with individual weights of approximately 0.25% and 1.25%.